Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.02 |
mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |